These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 33265989)
1. EcDBS1R4, an Antimicrobial Peptide Effective against Makowski M; Felício MR; Fensterseifer ICM; Franco OL; Santos NC; Gonçalves S Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33265989 [TBL] [Abstract][Full Text] [Related]
2. Activity modulation of the Makowski M; Almendro-Vedia VG; Domingues MM; Franco OL; López-Montero I; Melo MN; Santos NC iScience; 2023 Jul; 26(7):107004. PubMed ID: 37416464 [TBL] [Abstract][Full Text] [Related]
3. Differential interactions of the antimicrobial peptide, RQ18, with phospholipids and cholesterol modulate its selectivity for microorganism membranes. Almeida CV; de Oliveira CFR; Dos Santos EL; Dos Santos HF; Júnior EC; Marchetto R; da Cruz LA; Ferreira AMT; Gomes VM; Taveira GB; Costa BO; Franco OL; Cardoso MH; Macedo MLR Biochim Biophys Acta Gen Subj; 2021 Sep; 1865(9):129937. PubMed ID: 34052310 [TBL] [Abstract][Full Text] [Related]
4. The introduction of L-phenylalanine into antimicrobial peptide protonectin enhances the selective antibacterial activity of its derivative phe-Prt against Gram-positive bacteria. Peng J; Qiu S; Jia F; Zhang L; He Y; Zhang F; Sun M; Deng Y; Guo Y; Xu Z; Liang X; Yan W; Wang K Amino Acids; 2021 Jan; 53(1):23-32. PubMed ID: 33236256 [TBL] [Abstract][Full Text] [Related]
5. Dual action of BPC194: a membrane active peptide killing bacterial cells. Moiset G; Cirac AD; Stuart MC; Marrink SJ; Sengupta D; Poolman B PLoS One; 2013; 8(4):e61541. PubMed ID: 23620763 [TBL] [Abstract][Full Text] [Related]
6. Structural Disruptions of the Outer Membranes of Gram-Negative Bacteria by Rationally Designed Amphiphilic Antimicrobial Peptides. Gong H; Hu X; Liao M; Fa K; Ciumac D; Clifton LA; Sani MA; King SM; Maestro A; Separovic F; Waigh TA; Xu H; McBain AJ; Lu JR ACS Appl Mater Interfaces; 2021 Apr; 13(14):16062-16074. PubMed ID: 33797891 [TBL] [Abstract][Full Text] [Related]
7. Multiple Mechanisms of the Synthesized Antimicrobial Peptide TS against Gram-Negative Bacteria for High Efficacy Antibacterial Action In Vivo. Zhang R; Fan X; Jiang X; Zou M; Xiao H; Wu G Molecules; 2020 Dec; 26(1):. PubMed ID: 33374458 [TBL] [Abstract][Full Text] [Related]
10. Dual mechanism of bacterial lethality for a cationic sequence-random copolymer that mimics host-defense antimicrobial peptides. Epand RF; Mowery BP; Lee SE; Stahl SS; Lehrer RI; Gellman SH; Epand RM J Mol Biol; 2008 May; 379(1):38-50. PubMed ID: 18440552 [TBL] [Abstract][Full Text] [Related]
11. Newly designed antimicrobial peptides with potent bioactivity and enhanced cell selectivity prevent and reverse rifampin resistance in Gram-negative bacteria. Zhu N; Zhong C; Liu T; Zhu Y; Gou S; Bao H; Yao J; Ni J Eur J Pharm Sci; 2021 Mar; 158():105665. PubMed ID: 33285267 [TBL] [Abstract][Full Text] [Related]
12. Bacteria May Cope Differently from Similar Membrane Damage Caused by the Australian Tree Frog Antimicrobial Peptide Maculatin 1.1. Sani MA; Henriques ST; Weber D; Separovic F J Biol Chem; 2015 Aug; 290(32):19853-62. PubMed ID: 26100634 [TBL] [Abstract][Full Text] [Related]
13. Salt-resistant short antimicrobial peptides. Mohanram H; Bhattacharjya S Biopolymers; 2016 May; 106(3):345-56. PubMed ID: 26849911 [TBL] [Abstract][Full Text] [Related]
14. Fish-derived antimicrobial peptides: Activity of a chionodracine mutant against bacterial models and human bacterial pathogens. Buonocore F; Picchietti S; Porcelli F; Della Pelle G; Olivieri C; Poerio E; Bugli F; Menchinelli G; Sanguinetti M; Bresciani A; Gennari N; Taddei AR; Fausto AM; Scapigliati G Dev Comp Immunol; 2019 Jul; 96():9-17. PubMed ID: 30790604 [TBL] [Abstract][Full Text] [Related]
15. Interaction of the cyclic antimicrobial cationic peptide bactenecin with the outer and cytoplasmic membrane. Wu M; Hancock RE J Biol Chem; 1999 Jan; 274(1):29-35. PubMed ID: 9867806 [TBL] [Abstract][Full Text] [Related]
16. Antimicrobial peptides with symmetric structures against multidrug-resistant bacteria while alleviating antimicrobial resistance. Zhong C; Zhang F; Yao J; Zhu Y; Zhu N; Zhang Y; Liu H; Gou S; Ni J Biochem Pharmacol; 2021 Apr; 186():114470. PubMed ID: 33610592 [TBL] [Abstract][Full Text] [Related]
17. Increasing the Antimicrobial Activity of Nisin-Based Lantibiotics against Gram-Negative Pathogens. Li Q; Montalban-Lopez M; Kuipers OP Appl Environ Microbiol; 2018 Jun; 84(12):. PubMed ID: 29625984 [TBL] [Abstract][Full Text] [Related]
18. Unravelling the mechanism of action of "de novo" designed peptide P1 with model membranes and gram-positive and gram-negative bacteria. Espeche JC; Martínez M; Maturana P; Cutró A; Semorile L; Maffia PC; Hollmann A Arch Biochem Biophys; 2020 Oct; 693():108549. PubMed ID: 32828795 [TBL] [Abstract][Full Text] [Related]
19. Antimicrobial peptide activity is anticorrelated with lipid a leaflet affinity. Nelson N; Opene B; Ernst RK; Schwartz DK PLoS One; 2020; 15(11):e0242907. PubMed ID: 33253275 [TBL] [Abstract][Full Text] [Related]